RESUMO
The Plasmodium falciparum erythrocyte-membrane-protein-1 (PF3D7_1150400/PF11_0521) contains both domain cassette DC13 and DBLß3 domain binding to EPCR and ICAM-1 receptors, respectively. This type of PfEMP1 proteins with dual binding specificity mediate specific interactions with brain micro-vessels endothelium leading to the development of cerebral malaria (CM). Using plasma collected from children at time of hospital admission and after 30 days, we study an acquisition of IgG response to PF3D7_1150400/PF11_0521 DC13 and DBLß3_D4 recombinant constructs, and five peptides located within these constructs, specifically in DBLα1.7_D2 and DBLß3_D4 domains. We found significant IgG responses against the entire DC13, PF11_0521_DBLß3_D4 domain, and peptides. The responses varied against different peptides and depended on the clinical status of children. The response was stronger at day 30, and mostly did not differ between CM and uncomplicated malaria (UM) groups. Specifically, the DBLß3 B3-34 peptide that contains essential residues involved in the interaction between PF11_0521 DBLß3_D4 domain and ICAM-1 receptor demonstrated significant increase in reactivity to IgG1 and IgG3 antibodies at convalescence. Further, IgG reactivity in CM group at time of admission against functionally active (ICAM-1-binding) PF11_0521 DBLß3_D4 domain was associated with protection against severe anemia. These results support development of vaccine based on the PF3D7_1150400/PF11_0521 structures to prevent CM.
Assuntos
Imunoglobulina G/sangue , Malária Cerebral/imunologia , Malária Falciparum/imunologia , Peptídeos/imunologia , Proteínas de Protozoários/imunologia , Anemia/complicações , Anticorpos Antiprotozoários/sangue , Anticorpos Antiprotozoários/imunologia , Antígenos de Protozoários/sangue , Antígenos de Protozoários/imunologia , Encéfalo/imunologia , Encéfalo/metabolismo , Encéfalo/parasitologia , Encéfalo/patologia , Pré-Escolar , Receptor de Proteína C Endotelial/genética , Receptor de Proteína C Endotelial/imunologia , Endotélio Vascular/metabolismo , Endotélio Vascular/parasitologia , Eritrócitos/parasitologia , Feminino , Humanos , Imunoglobulina G/imunologia , Lactente , Molécula 1 de Adesão Intercelular/genética , Molécula 1 de Adesão Intercelular/imunologia , Malária Cerebral/sangue , Malária Cerebral/genética , Malária Cerebral/parasitologia , Malária Falciparum/sangue , Malária Falciparum/genética , Malária Falciparum/parasitologia , Masculino , Peptídeos/genética , Plasmodium falciparum/genética , Plasmodium falciparum/patogenicidade , Ligação Proteica/genética , Ligação Proteica/imunologia , Proteínas de Protozoários/genéticaRESUMO
Plasmodium falciparum is responsible of severe malaria, including cerebral malaria (CM). During its intra-erythrocytic maturation, parasite-derived proteins are expressed, exported and presented at the infected erythrocyte membrane. To identify new CM-specific parasite membrane proteins, we conducted a mass spectrometry-based proteomic study and compared the protein expression profiles between 9 CM and 10 uncomplicated malaria (UM) samples. Among the 1097 Plasmodium proteins identified, we focused on the 499 membrane-associated and hypothetical proteins for comparative analysis. Filter-based feature selection methods combined with supervised data analysis identified a subset of 29 proteins distinguishing CM and UM samples with high classification accuracy. A hierarchical clustering analysis of these 29 proteins based on the similarity of their expression profiles revealed two clusters of 15 and 14 proteins, respectively under- and over-expressed in CM. Among the over-expressed proteins, the MESA protein is expressed at the erythrocyte membrane, involved in proteins trafficking and in the export of variant surface antigens (VSAs), but without antigenic function. Antigen 332 protein is exported at the erythrocyte, also involved in protein trafficking and in VSAs export, and exposed to the immune system. Our proteomics data demonstrate an association of selected proteins in the pathophysiology of CM.
Assuntos
Malária Cerebral/parasitologia , Malária Falciparum/parasitologia , Plasmodium falciparum/química , Proteoma , Proteínas de Protozoários/análise , Algoritmos , Membrana Eritrocítica/química , Eritrócitos/parasitologia , Humanos , Malária Cerebral/fisiopatologia , Malária Falciparum/fisiopatologia , Proteínas de Membrana/análise , Proteínas de Membrana/isolamento & purificação , Plasmodium falciparum/isolamento & purificação , Análise de Componente Principal , Proteínas de Protozoários/isolamento & purificação , Espectrometria de Massas em Tandem , TranscriptomaRESUMO
BACKGROUND: The three members of the ring-infected erythrocyte surface antigen (RESA) proteins family share high sequence homologies, which impair the detection and assignment to one or another protein of some pathogenic processes inherent to Plasmodium falciparum malaria. The present study was intended to determine if the antibody and inflammatory responses of children living in a malaria-endemic area varied depending on the RESA-1, RESA-2 or RESA-3 proteins and the severity of the disease, two groups of severe and uncomplicated malaria cases being considered. METHODS: Two synthetic peptides representing predicted B cell epitopes were designed per RESA protein, all located outside of the 3' and 5' repetition blocks, in order to allow an antibody detection specific of each member of the family. Recombinant rRESA-1B and rRESA-3B proteins were also engineered. Two groups of Beninese children admitted to hospital in 2009 for either uncomplicated or severe malaria were compared for their plasma levels of IgG specifically recognizing each recombinant RESA protein or synthetic peptide, and for their plasma inflammatory cytokine levels (IFN-γ, TNF-α and IL-10), taking into account host and parasite genetic factors. RESULTS: The absence of IgG cross-reactivity between rRESA proteins and their protein carrier as well as between each RESA peptide and a non-epitopic RESA control peptide validated the use of the engineered recombinant proteins and peptides for the measurement of plasma IgG. Taking into account age, fever duration and parasitaemia, a multiple logistic regression performed on children clustered according to their antibody responses' profiles concluded to an increased risk of severe malaria for P2 (representative of RESA-1) responders (P = 0.007). Increased IL-10 plasma levels were found in children harbouring multiclonal P. falciparum infections on the basis of the T1526G resa2 gene polymorphism (P = 0.004). CONCLUSIONS: This study provided novel tools to dissect the seroreactivity against the three members of the RESA protein family and to describe its relation to protection against malaria. It suggested the measurement of plasma antibodies raised against specific peptides to serve as predictive immunologic markers for disease severity. Lastly, it reinforced previous observations linking the T1526G resa2 gene mutation to severe malaria.
Assuntos
Anticorpos Antiprotozoários/imunologia , Malária Falciparum/imunologia , Plasmodium falciparum/imunologia , Proteínas de Protozoários/imunologia , Anticorpos Antiprotozoários/sangue , Benin/epidemiologia , Criança , Pré-Escolar , Estudos Transversais , Citocinas/sangue , Citocinas/imunologia , Feminino , Humanos , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Lactente , Malária Falciparum/epidemiologia , Masculino , Proteínas Recombinantes/imunologiaRESUMO
Loss of endothelial protein C receptor (EPCR) occurs at the sites of Plasmodium falciparum-infected erythrocyte sequestration in patients with or who died from cerebral malaria. In children presenting with different clinical syndromes of malaria, we assessed the relationships between endogenous plasma soluble EPCR (sEPCR) levels and clinical presentation or mortality. After adjustment for age, for treatment before admission, and for a known genetic factor, sEPCR level at admission was positively associated with cerebral malaria (P = .011) and with malaria-related mortality (P = .0003). Measuring sEPCR levels at admission could provide an early biological marker of the outcome of cerebral malaria.
Assuntos
Antígenos CD/sangue , Malária Cerebral/sangue , Malária Cerebral/mortalidade , Receptores de Superfície Celular/sangue , Antígenos CD/metabolismo , Antimaláricos/uso terapêutico , Benin/epidemiologia , Pré-Escolar , Receptor de Proteína C Endotelial , Genótipo , Humanos , Malária Cerebral/tratamento farmacológico , Malária Cerebral/epidemiologia , Quinina/uso terapêutico , Receptores de Superfície Celular/metabolismoRESUMO
BACKGROUND: Cytoadherence of Plasmodium falciparum-infected erythrocytes (IEs) in deep microvasculature endothelia plays a major role in the pathogenesis of cerebral malaria (CM). This biological process is thought to be mediated by P. falciparum erythrocyte membrane protein-1 (PfEMP-1) and human receptors such as CD36 and ICAM-1. The relationship between the expression of PfEMP-1 variants and cytoadherence phenotype in the pathology of malaria is not well established. METHODS: Cytoadherence phenotypes of IEs to CD36, ICAM-1, CSPG and the transcription patterns of A, B, var2csa, var3, var gene groups and domain cassettes DC8 and DC13 were assessed in parasites from children with CM and uncomplicated malaria (UM) to determine if cytoadherence is related to a specific transcription profile of pfemp-1 variants. RESULTS: Parasites from CM patients bind significantly more to CD36 than those from UM patients, but no difference was observed in their binding ability to ICAM-1 and CSPG. CM isolates highly transcribed groups A, B, var2csa, var3, DC8 and DC13 compared to UM parasites. The high transcription levels of var genes belonging to group B positively correlated with increased binding level to CD36. CONCLUSION: CM isolates bind significantly more to CD36 than to ICAM-1, which was correlated with high transcription level of group B var genes, supporting their implication in malaria pathogenesis.
Assuntos
Adesão Celular , Eritrócitos/fisiologia , Eritrócitos/parasitologia , Malária Cerebral/patologia , Plasmodium falciparum/crescimento & desenvolvimento , Proteínas de Protozoários/biossíntese , Antígenos CD36/metabolismo , Criança , Eritrócitos/química , Expressão Gênica , Genótipo , Humanos , Molécula 1 de Adesão Intercelular/metabolismo , Malária Cerebral/parasitologia , Proteínas de Protozoários/genética , Receptores de Superfície Celular/metabolismoRESUMO
BACKGROUND: Plasmodium falciparum exports proteins that remodel the erythrocyte membrane. One such protein, called Pf155/RESA (RESA1) contributes to parasite fitness, optimizing parasite survival during febrile episodes. Resa1 gene is a member of a small family comprising three highly related genes. Preliminary evidence led to a search for clues indicating the involvement of RESA2 protein in the pathophysiology of malaria. In the present study, cDNA sequence of resa2 gene was obtained from two different strains. The proportion of P. falciparum isolates having a non-stop T1526C mutation in resa2 gene was evaluated and the association of this genotype with severity of malaria was investigated. METHODS: Resa2 cDNAs of two different strains (a patient isolate and K1 culture adapted strain) was obtained by RT-PCR and DNA sequencing was performed to confirm its gene structure. The proportion of isolates having a T1526C mutation was evaluated using a PCR-RFLP methodology on groups of severe malaria and uncomplicated patients recruited in 1991-1994 in Senegal and in 2009 in Benin. RESULTS: A unique ORF with an internal translation stop was found in the patient isolate (Genbank access number : JN183870), while the K1 strain harboured the T1526C mutation (Genbank access number : JN183869) which affects the internal stop codon and restores a full length coding sequence. About 14% of isolates obtained from Senegal and Benin harboured mutant T1526C parasites. Some isolates had both wild and mutant resa alleles. The analysis excluding those mixed isolates showed that the resa2 T1526C mutation was found more frequently in severe malaria cases than in uncomplicated cases (p = 0.008). The association of the presence of the mutant allele and parasitaemia >4% was shown in multivariate analysis (p = 0.03) in the group of Beninese children. CONCLUSIONS: All T1526C mutant parasites theoretically have the ability to give rise to a full-length RESA2 protein. This study raises the hypothesis that the RESA2 protein could favour high-density infections. Other studies in various geographic settings and probably including more patients are now required to replicate these results and to answer the questions raised by these results.
Assuntos
Malária Falciparum/patologia , Malária Falciparum/parasitologia , Plasmodium falciparum/genética , Plasmodium falciparum/patogenicidade , Mutação Puntual , Proteínas de Protozoários/genética , Fatores de Virulência/genética , Adolescente , Adulto , Animais , Benin , Criança , Pré-Escolar , Análise Mutacional de DNA , DNA Complementar/química , DNA Complementar/genética , DNA de Protozoário/química , DNA de Protozoário/genética , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Polimorfismo de Fragmento de Restrição , Proteínas de Protozoários/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Senegal , Análise de Sequência de DNA , Fatores de Virulência/metabolismo , Adulto JovemRESUMO
Objectif : L'étude avait pour objectif principal de décrire le profil de prescription du traitement antirétroviral chez les enfants infectés par le VIH au Bénin. Secondairement, l'étude devait décrire les modalités de changement de la trithérapie antirétrovirale initiale et les causes du changement. Méthodes : Etude rétrospective descriptive de janvier 2002 à juillet 2013 ayant pris en compte 237 enfants dans le service de pédiatrie du Centre National Hospitalier et Universitaire Hubert Koutoukou Maga (CNHU-HKM) de Cotonou. Résultats : Le schéma thérapeutique le plus utilisé était : deux inhibiteurs nucléosidiques de la transcriptase inverse (INTI) + un inhibiteur non nucléosidique de la transcriptase inverse (INNTI). La trithérapie la plus utilisée était lamivudine-zidovudine-efavirenz ou 3TC+AZT+EFV (25,23%). Les associations lamivudine-zidovudine-névirapine (24,62%) et 3TC+AZT+NFV (20%) étaient les moins tolérées. La cause de modification de traitement la plus fréquente était les ruptures de stocks. Conclusion : Au Bénin, l'initiation des ARV chez les enfants est assez fréquemment tardive avec des changements forcés de protocoles et même l'utilisation d'associations d'ARV déconseillées à cause de rupture de certains médicaments